t-cells

Documents about t-cells

• Primate resident memory T cells activate humoral and stromal immunity.#150123NCBI PubMed Central
• Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors#184868ClinicalTrials.gov
• Unbiased avidity-based isolation of antigen-specific T cells.#358519NCBI PubMed Central
• Dynein-microtubule forces drive nucleokinesis and transmigration in T cells#438483bioRxiv / medRxiv
• Tunable universal OR-gated CAR T cells for AML.#452919NCBI PubMed Central
• Integrating AI, RNA Vaccines, and CAR‐T Cells for Personalized Treatment#643277HAL (France)
• Imaging the fate of CAR-T cells in vivo.#653467NCBI PubMed Central
• A Study of CAR-T Cells Targeting Autoimmune Diseases#903265ClinicalTrials.gov
• Mucosal-Associated Invariant T Cells in Health and Disease.#975716NCBI PubMed Central
• CAR T-cells for the treatment of CNS malignancies.#1001171NCBI PubMed Central
• Table 1_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224166Figshare
• Table 2_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224167Figshare
• Table 3_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224169Figshare
• Table 7_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224170Figshare
• Table 8_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224171Figshare
• Table 4_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224174Figshare
• Table 5_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.xlsx#224175Figshare
• Identification of human DP8α regulatory T cell sub-populations reactive to health-associated anti-inflammatory gut commensals#347889HAL (France)
• CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.#843826ClinicalTrials.gov
• CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS#864012ClinicalTrials.gov
• Vitamin D Supplementation in Systemic Lupus Erythematosus#851335ClinicalTrials.gov
• Genetic Engineering of Notch1 Regulatory Elements to Improve CD19 CAR T-cell Proliferation and Persistence#273814Harvard DASH
• Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers#383557ClinicalTrials.gov
• Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases#853824ClinicalTrials.gov
• Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy#126895HAL (France)
• Remodeling memory T cells with chemotherapy and immune checkpoint inhibitors as host pre-conditioning to empower in vivo CAR-T therapy#253510Europe PMC
• Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T Cells#148768ClinicalTrials.gov
• Supplementary file 1_Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.pdf#224165Figshare
• Co-regulation of HIV control and cytomegalovirus pp65-specific IL-1β and TNF-α responses by genetic variants in the MHC region#368467PLOS
• Resposta imune a antígenos de Mycobacterium leprae e apresentação clínica da hanseníase como perspectiva para o desenvolvimento de ferramentas para prognóstico e imunoprofilaxia#646882Repositório Institucional da Universidade Federal de Sergipe
• The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)#804612ClinicalTrials.gov
• CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma#865026ClinicalTrials.gov
• A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies#992405ClinicalTrials.gov
• Impaired suppressive effect of FoxP3 regulatory T cells on B cells in multiple sclerosis#212949Europe PMC
• Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer#217018ClinicalTrials.gov
• Is the metabolism of CD8+ T-cells special?#221984ScholarlyCommons at Penn
• Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia#992060ClinicalTrials.gov
• REGulatory T Cells in Autism Induced by Maternal Immune Activation#993013ClinicalTrials.gov
• Positioning of living cells on SiO2 micronozzles for electrical characterization#177963Infoscience
• MSLN STAR-T Cells in the Treatment of Advanced Malignant Solid Tumors#226246ClinicalTrials.gov
• Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases#387166ClinicalTrials.gov
• Characterization of the Human Dopamine Transporter Heterologously Expressed in BHK-21 Cells#395385HAL (France)
• Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)#411381ClinicalTrials.gov
• Human epidermal resident memory T cells: beyond the dermal perspective.#418442NCBI PubMed Central
• Vγ9Vδ2 T cells in tuberculosis: protective immunity and translational perspectives.#465192NCBI PubMed Central
• Levels of Circulating T Cells Expressing VLA-1 Collagen Receptors#835780ClinicalTrials.gov
• Understanding the regulators of adaptive tolerance in chronically stimulated CD4+ T-cells.#1055405UBIRA ETheses
• Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner#643942IBISS
• LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies#846631ClinicalTrials.gov
• Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)#881243ClinicalTrials.gov